Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-097509
Filing Date
2025-10-07
Accepted
2025-10-07 16:16:57
Documents
19
Period of Report
2025-11-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A rzlt-20251119xdef14a.htm   iXBRL DEF 14A 841213
2 GRAPHIC rzlt-20251119xdef14a_a011.jpg GRAPHIC 61409
3 GRAPHIC rzlt-20251119xdef14a_a012.jpg GRAPHIC 57427
4 GRAPHIC rzlt-20251119xdef14a_bg001.jpg GRAPHIC 133658
5 GRAPHIC rzlt-20251119xdef14a_bg002.jpg GRAPHIC 87221
  Complete submission text file 0001104659-25-097509.txt   2522466

Data Files

Seq Description Document Type Size
6 EX-101.SCH rzlt-20251119.xsd EX-101.SCH 3203
7 EX-101.LAB rzlt-20251119_lab.xml EX-101.LAB 3685
8 EX-101.PRE rzlt-20251119_pre.xml EX-101.PRE 3939
21 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20251119xdef14a_htm.xml XML 273081
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39683 | Film No.: 251380039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)